LifePoint to start clinical trials for Impact system:
This article was originally published in Clinica
Executive Summary
LifePoint is set to begin a US and Canadian multicentre clinical trials of its rapid, saliva-based drugs-of-abuse/alcohol Impact test system. The test, which the company claims is the only product of its kind that can perform alcohol and drug testing simultaneously, detectS markers in saliva and correlates them to equivalent levels in blood. Data generated from the trial will form the basis of the Ontario, California company's 510(k) marketing application to the FDA.